Related Experiment Video
Updated: Jul 9, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Risk Adjustment for the Medicare program: lessons learned from research and demonstrations
L M Greenwald1, A Esposito, M J Ingber
1Division of Payment Research, Research and Evaluation Group, Baltimore, MD 21244, USA.
The Balanced Budget Act of 1997 reshaped Medicare, introducing "Medicare + Choice" with new payment structures. This paper reviews historical risk adjustment research and proposes an approach for its 2000 implementation.
Area of Science:
- Health Policy
- Medicare Managed Care
- Health Economics
Background:
- The Balanced Budget Act of 1997 mandated significant changes to the Medicare program.
- Medicare's managed care component was restructured into "Medicare + Choice," expanding beneficiary options and altering payment schedules.
Purpose of the Study:
- To provide an overview of risk adjustment research and demonstration activities conducted by the Health Care Financing Administration (HCFA) since the 1980s.
- To describe a potential technical strategy for implementing risk-adjusted payments in Medicare managed care by the year 2000.
Main Methods:
- Review of historical Health Care Financing Administration (HCFA) research and demonstration projects.
- Description of a technical approach for risk-adjusted payment implementation.
Main Results:
- Years of research and development preceded the Balanced Budget Act's mandated changes.
- Risk-adjusted payment for Medicare + Choice, mandated for 2000, is a key developmental initiative.
Conclusions:
- The Balanced Budget Act necessitates substantial adjustments to Medicare.
- Risk adjustment is a critical component for the successful implementation of Medicare + Choice payments.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Dosing: Geriatric Patients
Hazard Ratio
For example, in a clinical trial evaluating a...

